Condition

Radiation Toxicity

ClinicalTrials.gov condition label

Clinical trials51

Recruiting5

Common interventions25

Lead sponsors shown15

Clinical trials

51 shown

Curatively Intended Thoracic ReirradiationNCT06950073 · 2025-10-10

A Study to Determine the Preferred Dose of the Drug, Lisinopril, for Preventing Urinary Toxicity Following Radiotherapy for Prostate CancerNCT05530655 · 2024-02-20

Salvage Hypofractionated Accelerated Versus Standard Radiotherapy for Biochemical Failure After ProstatectomyNCT03920033 · 2019-05-01

The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac StudyNCT04075305 · 2019-02-01

COr Loco-regional Advanced Lung Cancer Treated With Chemo-radiotherapy (COLA)NCT05258448 · 2015-08-01

Atrial Fibrillation and Other Cardiac Arrhythmias and Diseases After Radiotherapy for Breast Cancer : Watch Your HeaRTNCT06073509 · 2023-10-25

Acute Toxicity After Moderate Hypo-fractionated Intensity Modulated Radiotherapy IMRT or Prostate CancerNCT05265364 · 2022-07-25

Pilot Study of the Predictive Value of TREM1 Expression and Activation in Inflammation and Radio-induced Mammary FibrosisNCT04948840 · 2022-04-01

Shared Decision Making on Radiation Dose for Lung MalignanciesNCT04940936 · 2021-11-12

ACTIVE_NOT_RECRUITING

Hypo-Combi Trial: Hypofractionated EBRT Plus HDR-BT Boost for Prostate CancerNCT05003752 · 2021-08-01

ACTIVE_NOT_RECRUITING

A Behavioral Health Intervention Using Digital Technology in Radiation Therapy for Prostate Cancer PatientsNCT04946214 · 2021-05-26

Radiation-induced Cardiac Toxicity After Non-small Cell Lung Cancer RadiotherapyNCT04867564 · 2021-05-01

Cardiotoxicity in Locally Advanced Lung Cancer Patients Treated With Chemoradiation TherapyNCT04305613 · 2020-09-14

ACTIVE_NOT_RECRUITING

Cicaderma Efficacy vs Standard Care of Sites in Preventing Radiodermatitis in Non-metastatic Breast Cancer PatientsNCT04300829 · 2020-06-06

The Effect of Hyperbaric OxygeN Therapy on brEast Cancer Patients With Late Radiation toxicitY - UMBRELLA HONEY TrialNCT04193722 · 2019-08-28

Hypofractionated Versus Conventional Fractionation RadiotherapyNCT04015531 · 2019-07-01

Hybrid PET/MR Imaging of Acute Cardiac Inflammation After Left-Sided Breast Cancer RadiotherapyNCT03748030 · 2019-01-01

Photobiomodulation for Breast Cancer RadiodermatitisNCT04059809 · 2018-09-26

Pre- or Postoperative Accelerated RadiotherapyNCT03783364 · 2018-09-17

Detecting Radiation-Induced Cardiac Toxicity After Non-Small Cell Lung Cancer RadiotherapyNCT03416972 · 2018-01-11

A Prospective Study of Hypothyroidism After Radiotherapy for Breast CancerNCT04528225 · 2017-11-15

Prospective Assessment of Radiation-induced Heart Injury in Left-sided Breast CancerNCT03461588 · 2017-01-01

Temperature and Injury in Radiotherapy Radiation Skin InjuryNCT04047823 · 2016-10-02

3DCRT vs. IMRT in Early Breast CancerNCT02440191 · 2015-05-01

Pulmonary Rehabilitation in Improving Lung Function in Patients With Locally Advanced Non-Small Cell Lung Cancer Undergoing ChemoradiationNCT02017925 · 2013-10-01

Whole Breast Irradiation vs Twice Daily vs. Once Daily Accelerated Partial Breast IrradiationNCT03616626 · 2013-07-01

Pilot Trial Evaluating Stereotactic Body Radiotherapy With Integrated Boost for Clinically Localized Prostate Cancer (RAD 1203)NCT01856855 · 2013-02-01

Metabolomic and Epigenetic Profiling of Bodyfluids From Lung and Brain Cancer Receiving Radiation TherapyNCT02259218 · 2012-10-04

Genetic Susceptibility to Radiation-Induced Skin Reactions in Racial/Ethnic Groups of Patients With Breast CancerNCT01407770 · 2011-09-20

Radiation Therapy in Treating Patients With Prostate CancerNCT01434290 · 2011-09-01

L-Arginine Supplementation With or Without Enzyme Inhibitors Treating Erectile Function of Prostate Cancer SurvivorsNCT01105130 · 2010-10-01

Alkaline Water in Reducing Skin Toxicity in Women With Breast Cancer Undergoing Radiation TherapyNCT01487954 · 2010-05-01

Neoadjuvant Therapy for Esophageal Cancer and Cardiopulmonary PhysiologyNCT03462524 · 2010-01-01

Lovastatin in Reducing Side Effects After Radiation Therapy in Women With Breast CancerNCT00902668 · 2009-04-01

Hyperbaric Oxygen Therapy in Treating Long-Term Gastrointestinal Adverse Effects Caused by Radiation Therapy in Patients With Pelvic CancerNCT01087268 · 2009-01-01

Flaxseed Supplement in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Undergoing Chemotherapy and Radiation TherapyNCT00955942 · 2007-12-01

High-Dose or Standard-Dose Radiation Therapy and Chemotherapy With or Without Cetuximab in Treating Patients With Newly Diagnosed Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by SurgeryNCT00533949 · 2007-11-01

Mometasone Furoate in Preventing Radiation Dermatitis in Patients Undergoing Radiation Therapy to the Breast or Chest Wall for Invasive Breast Cancer or Ductal Carcinoma in SituNCT00438659 · 2007-08-01

Accelerated Partial Breast Irradiation With 3D-CRT and IMRTNCT02003560 · 2006-12-01

Low-Residue Diet in Treating Diarrhea in Patients Receiving Pelvic Radiation Therapy.NCT00258401 · 2005-05-01

Sildenafil in Treating Erectile Dysfunction in Patients With Prostate CancerNCT00057759 · 2003-01-01

Intensity Modulated Radiotherapy With Concomitant Boost in Breast CancerNCT03471741 · 2001-06-01

Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung CancerNCT00006012 · 2001-02-01

Donepezil and Vitamin E to Prevent Side Effects Caused By Radiation Therapy to the Head in Patients Receiving Treatment for Small Cell Lung CancerNCT00006349 · 2001-02-01

Modulated Accelerated RAdiotherapy in Early Breast CancerNCT03461224 · 2001-01-10

Amifostine, Chemotherapy, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung CancerNCT00004176 · 1998-10-01

Amifostine in Treating Patients With Stage II or Stage III Non-small Cell Lung CancerNCT00003313 · 1998-09-01

Radiation Therapy Plus Amifostine in Treating Patients With Primary Prostate CancerNCT00003307 · 1998-03-01

Amifostine to Prevent Side Effects in Patients Who Are Receiving Chemotherapy and Radiation Therapy for Limited-Stage Small Cell Lung CancerNCT00003583 · 1997-06-01

Predicting the Risk of Failure in Patients Undergoing Radiation Therapy for Localized Prostate CancerNCT00769223 · 1993-02-25

ACTIVE_NOT_RECRUITING

Return to Work Among Cancer Survivors With Treatment-induced Survivorship SyndromesNCT03961217 · 1991-01-01

Common interventions

Leading sponsors

Radiation Therapy Oncology Group4 Abramson Cancer Center at Penn Medicine2 Alliance for Clinical Trials in Oncology2 Case Comprehensive Cancer Center2 IRCCS Azienda Ospedaliero-Universitaria di Bologna2 London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's2 Ohio State University Comprehensive Cancer Center2 UMC Utrecht2 Wake Forest University Health Sciences2 AC Camargo Cancer Center1 Asan Medical Center1 Cancer Institute and Hospital, Chinese Academy of Medical Sciences1 Centre Francois Baclesse, Luxembourg1 Centre Leon Berard1 German Oncology Center, Cyprus1

Trial status mix

COMPLETED25

UNKNOWN14

RECRUITING5

ACTIVE_NOT_RECRUITING4

TERMINATED2

WITHDRAWN1

Phase mix

NA12

PHASE211

PHASE39

PHASE13

EARLY_PHASE11

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.